{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:15:18Z","timestamp":1761988518753},"reference-count":15,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1128,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/j.1365-2710.2012.01369.x","type":"journal-article","created":{"date-parts":[[2012,7,30]],"date-time":"2012-07-30T07:27:24Z","timestamp":1343633244000},"page":"668-673","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics"],"prefix":"10.1155","volume":"37","author":[{"given":"M. T.","family":"DelMonte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Bostwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. D.","family":"Bess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. W.","family":"Dalack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,7,30]]},"reference":[{"issue":"Suppl. 4","key":"10.1111\/j.1365-2710.2012.01369.x-BIB1|cit1","first-page":"14","article-title":"Implementation of monitoring and management guidelines for second-generation antipsychotics","volume":"68","author":"Sernyak","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/JCP.v65n0219","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"65","author":"American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1176\/appi.ajp.162.6.1217","article-title":"Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications","volume":"162","author":"Straker","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1078345809340424","article-title":"Creation of a metabolic monitoring program for second-generation (atypical) antipsychotics","volume":"15","author":"Reeves","year":"2009","journal-title":"J Correct Health Care"},{"issue":"Suppl. 4","key":"10.1111\/j.1365-2710.2012.01369.x-BIB5|cit5","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.psym.2010.12.009","article-title":"Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans","volume":"52","author":"Chwastiak","year":"2011","journal-title":"Psychosomatics"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psc.2010.11.004","article-title":"Prevention of metabolic syndrome in serious mental illness","volume":"34","author":"Ganguli","year":"2011","journal-title":"Psychiatr Clin North Am"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1176\/appi.ajp.2008.08030383","article-title":"Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents","volume":"166","author":"Haupt","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4088\/JCP.v69n0219","article-title":"Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data","volume":"69","author":"Morrato","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2337\/dc08-1720","article-title":"Metabolic screening after the American Diabetes Association\u2019s consensus statement on antipsychotic drugs and diabetes","volume":"32","author":"Morrato","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archgenpsychiatry.2009.179","article-title":"Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA\/APA recommendations for second-generation antipsychotic drugs","volume":"67","author":"Morrato","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1592\/phco.29.8.975","article-title":"Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents","volume":"29","author":"Schneiderhan","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1001\/archinte.166.17.1848","article-title":"Improved therapeutic monitoring with several interventions: a randomized trial","volume":"166","author":"Feldstein","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/jamia.2010.005520","article-title":"Evaluation of computer-generated reminders to improve CD4 laboratory monitoring in sub-Saharan Africa: a prospective comparative study","volume":"18","author":"Were","year":"2011","journal-title":"J Am Med Inform Assoc"},{"key":"10.1111\/j.1365-2710.2012.01369.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1197\/jamia.M2687","article-title":"Impact of non-interruptive medication laboratory monitoring alerts in ambulatory care","volume":"16","author":"Lo","year":"2009","journal-title":"J Am Med Inform Assoc"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2012.01369.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2012.01369.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:35Z","timestamp":1671818675000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2012.01369.x"}},"subtitle":["Computer-based intervention to enhance metabolic monitoring"],"short-title":[],"issued":{"date-parts":[[2012,7,30]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2012.01369.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,30]]}}}